Medical Microbiology

StreptolysinO 238
StreptolysinS 238
Streptomycessomaliensis
652
Streptomycin 189
Strigeatida 545
Stripping 144
Stromalcells 62
Stromalcell-derivedfactor
(SDF) 83
Strongylida 545
Strongyloides(strongyloi-
dosis) 582 – 585, 602
clinicalmanifestations
584
diagnosis 584 – 585,626,
640 , 652
specimenhandling
622
fuelleborni 582 – 583
lifecycle 582 – 584
morphology 583
occurrence 582 – 583
pathogenesis 584
prevention 585
stercoralis 54 4,
582 – 583 , 640
therapy 585
Subacutesclerosingpan-
encephalitis(SSPE) 466
Subduralabscess 646
Subduralempyema 646
Sulfadoxine533, 534
Sulfonamides 19 4, 195 ,
533
mechanismsofaction
198 , 199
Sulfones 533
Superantigens 1 5, 17 , 72
endogenous 72
exogenous 72
T-cellactivation 72
Supercoil 181
Superinfection 10
Suppressorcell 144
Surfacedisinfection 41
Surfactants 40
Susceptibility8, 11
Swallowbug 616
Swimming-poolconjunc-
tivitis336, 339
Syngeneictransplants 11 6,
144
(2’-5’)(A)nSynthetase 401
Syphilis 320 – 323
clinicalpicture 320 – 321
diagnosis 321 – 322, 637 ,
651

antibodyassays 321 – 322 antilipoidalanti- bodies 321 – 322 immunofluores- cencetest(FTA-ABS) 322 Treponemapallidum immobilization (TPI)test 322 Treponemapallidum particleagglutina- tion(TP-PA) 322 pathogenidentifica- tion 321 epidemiology 323 latent 321 nonvenereal 323 prevention 323 stageI(primary) 321 stageII(secondary) 321 stageIII(tertiary/late) 321 syphilisconnata 321 therapy 323 seealsoTreponemapal- lidum

&T Tcells45, 46 – 4 8, 71 – 72 activation 71 – 7 2, 73 bysuperantigens 72 antigenrecognition 52 antiviralprotection79, 402 autoimmune 114 – 115 cytotoxicTcells(CD8+) 6 4–6 6 , 75 –7 6 perforin-dependent cytotoxicity 100 detectionof,tetramer test 131 , 134 helperTcells(CD4+) 6 4, 72 – 75, 141 subpopulations75, 78 interactions 72 – 75 inantigenrecognition 65 maturation 47 , 63 – 64 negativeselection46, 63 positiveselection 63 – 64 memory 95 – 96, 98 – 99 MHCrestriction58, 142 nonlyticresponses 100

specificity 62 subpopulations 64 – 66 tolerance 90 – 93 central 90 complete,exhaustive T-cellinduction 9 1–9 2 peripheral 90 – 91 T-cellindifference/ig- norance 91 cdTcells 66 T-celllymphoma 424 T-cellreceptor(TCR) 45 , 57 – 58, 62 geneticrearrangement 53,54, 55 Taenia(taeniosis) 54 4, 560 – 565 asiatica29, 562 saginata 560 – 563 clinicalmanifestations 562 diagnosis 56 2,625, 640 epidemiology 561 – 562 lifecycle 560 – 561 , 563 occurrence 560 pathogenesis 562 prevention 562 therapy 562 transmission 29 solium 564 clinicalmanifestations 564 cysticercosis 564 – 565 diagnosis 56 4,623, 625 cutaneousinfection 653 eyeinfection 657 gastrointestinal tract 640 muscleinfection 654 nervoussystem 646 lifecycle563, 564 occurrence 564 prevention 564 therapy 564 transmission 29 Tapeworms 560 beef 560 – 563 broad 575 – 576 dwarf 575 dwarfdog 566 – 571 dwarffox 571 – 574

TapewormsT 693

Medical Microbiology

Get our desktop app

Company

Features

Documentation

Resources